Items where authors include "Mason, C."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370

Mason, C. orcid.org/0009-0000-9622-0638, Tschirren, B. and Hemmings, N. orcid.org/0000-0003-2418-3625 (2024) Effects of female-specific selection for reproductive investment on male fertility traits. Journal of Evolutionary Biology, 37 (9). pp. 1113-1124. ISSN 1010-061X

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Graves, C.A., Benson, L., Aldridge, J. et al. (13 more authors) (2022) Sedimentary carbon on the continental shelf: Emerging capabilities and research priorities for Blue Carbon. Frontiers in Marine Science, 9. 926215. ISSN 2296-7745

Beresford-Dent, J. orcid.org/0000-0002-3316-2191, Sprange, K. orcid.org/0000-0001-6443-7242, Mountain, G. et al. (4 more authors) (2022) Embedding patient and public involvement in dementia research: Reflections from experiences during the ‘Journeying through Dementia’ randomised controlled trial. Dementia, 21 (6). pp. 1987-2003. ISSN 1471-3012

Humphrey, N., Hennessey, A., Troncoso, P. et al. (13 more authors) (2022) The Good Behaviour Game intervention to improve behavioural and other outcomes for children aged 7–8 years: a cluster RCT. Public Health Research, 10 (7). ISSN 2050-4381

Sprange, K., Beresford-Dent, J., Mountain, G. et al. (7 more authors) (2021) Assessing fidelity of a community based psychosocial intervention for people with mild dementia within a large randomised controlled trial. BMC Geriatrics, 21 (1). 119. ISSN 1471-2318

Sprange, K., Beresford-Dent, J., Mountain, G. et al. (4 more authors) (2021) Journeying through dementia randomised controlled trial of a psychosocial intervention for people living with early dementia: embedded qualitative study with participants, carers and interventionists. Clinical Interventions in Aging, 16. pp. 231-244. ISSN 1178-1998

Plews, J.R., Li, J.L., Jones, M. et al. (4 more authors) (2010) Activation of pluripotency genes in human fibroblast cells by a novel mRNA based approach. Plos One, 5 (12). Art no.e14397. ISSN 1932-6203